Family Wellness Antacid Tablets Recall Due to Metallic Particles
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA has announced a Class II recall of Family Wellness Ultra Strength Antacid tablets due to the presence of small metallic particles.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 9, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.
What Happened
Guardian Drug Co. Inc. initiated a voluntary recall of FAMILY WELLNESS ULTRA STRENGTH ASSORTED FRUIT ANTACID tablets due to the presence of foreign substance: small metallic particles in chewable tablets.
Which Products Are Affected
- Product: FAMILY WELLNESS, ULTRA STRENGT, ANTACID TABLETS, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS
- NDC: 55319-171-68
- Lot #: 1716089, expires: JAN 2029
- Distributed by: MIDWOOD BRANDS, LLC, 500 VOLVO PKWY, CHESAPEAKE, VA 23320 USA
- Distribution: U.S.A. Nationwide
- Recall Number: D-0568-2026
What You Should Do
Consumers should check product lot numbers against the recalled lot. No additional consumer instructions were provided in the recall announcement.
Why This Matters
This ongoing Class II recall affects antacid tablets distributed nationwide.
Source
FDA recall D-0568-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (866 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to July 9, 2026.
Frequently Asked Questions
Common questions about this FDA recall.